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Abstract: Vascular implants belong to a specialised class of medical textiles. The basic 
purpose of a vascular implant (graft and stent) is to act as an artificial conduit or substitute 
for a diseased artery. However, the long-term healing function depends on its ability to 
mimic the mechanical and biological behaviour of the artery. This requires a thorough 
understanding of the structure and function of an artery, which can then be translated into a 
synthetic structure based on the capabilities of the manufacturing method utilised. Common 
textile manufacturing techniques, such as weaving, knitting, braiding, and electrospinning, 
are frequently used to design vascular implants for research and commercial purposes for the 
past decades. However, the ability to match attributes of a vascular substitute to those of a native 
artery still remains a challenge. The synthetic implants have been found to cause disturbance in 
biological, biomechanical, and hemodynamic parameters at the implant site, which has been 
widely attributed to their structural design. In this work, we reviewed the design aspect of textile 
vascular implants and compared them to the structure of a natural artery as a basis for 
assessing the level of success as an implant. The outcome of this work is expected to encourage 
future design strategies for developing improved long lasting vascular implants. 
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1. Introduction 
The use of textiles for medical applications can be traced back to the early ages in wound care 
applications such as sutures and wound dressings. The suitability of textiles, whether in fibre or fabric 
form, lies in their structural flexibility, whereby some exhibit properties similar to human tissues, which 
are also composed of fibrous components. Another advantage of textile-based substrates is their design 
flexibility (from fibre to fabric stage), which can be modified to emulate the mechanical behaviour 
(elasticity, strength, stiffness, fluid permeability) of native biological tissue. These properties give 
textiles an edge over other materials (metals and plastics) in the area of soft tissue repair, for example, 
cardiovascular implants, which are used to replace/repair diseased arteries. 
Cardiovascular implant market (grafts and stents) is growing at a fast pace due to increasing number 
of patients with vascular diseases and limited biological replacement options available. Thus, synthetic 
implants offer off-the-shelf solution in a range of design specifications. During the last two decades, a 
significant amount of research and industry effort has been put into developing vascular implants 
intended for various anatomical locations. Among the soft tissue implants, design optimisation of 
vascular implants is considered as one of the most complex tasks and has therefore been a continuing 
challenge for biomedical device engineers. The reason for this is the inability to match biomechanical 
behaviour of a synthetic implant to that of an artery. This is due to the heterogeneous structure of an 
artery, which imparts unique mechanical features (non-linearity, anisotropy, viscoelasticity, compliance) 
in the vascular wall. An artery shows very low stress response at low pressures and exhibits a steep 
increase in elastic modulus as the pressure is increased, a property known as non-linearity or incremental 
elastic modulus (Figure 1). Simultaneously, geometrical arrangement of structural components in the 
vessel wall imparts anisotropy characteristic to its mechanical behaviour. On the other hand, a synthetic 
arterial substitute (woven Dacron® graft) is a homogenous structure, which exhibits low elasticity and 
relatively higher linear stress response at similar levels of strain (Figure 1) [1]. The viscoelasticity 
property is another important component that determines the hemodynamic behaviour of an arterial 
vessel and is an equally difficult feature to mimic in a synthetic implant. When an artery is subjected to 
cyclic inflation-deflation stresses, it does not react instantaneously to these stresses [2,3]. Instead, the 
artery, due to it being viscoelastic, produces a delayed response known as hysteresis when subjected to 
changes in pressure and volume (Figure 1). In addition to the biomechanical properties mentioned above, 
compliance, defined as radial extensibility of an artery in the physiological pressure range (80–120 mmHg) 
plays a decisive role in vascular mechanics. In a synthetic implant, this property is directly related to 
structural construction and material property, and hence highly variable. An unmatched compliance 
between an artery and implant is a common cause of long-term complications which result in ultimate 
failure of the surgical procedure due to altered pressure and flow dynamics [4,5]. Therefore, the design 
feature of medical textiles is critical when they are being considered for vascular implant applications.  
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Figure 1. Comparison of pressure-diameter curves between an artery and a synthetic implant. 
Synthetic vascular implants are currently manufactured using standard textile manufacturing 
techniques such as weaving, knitting, braiding and electrospinning. A number of reviews have reported 
on the mechanical property comparisons of different types of vascular grafts and their clinical 
performance [6–8]. In 1986, Pourdeyhimi and Wagner presented an extensive review focusing on 
structures of the synthetic grafts to explain the reported clinical observations of these grafts [9,10]. 
However, recent studies on grafts and stents rarely consider the effect manufacturing techniques have 
on the structure. This paper will discuss the structure of vascular implants produced by different textile 
manufacturing methods and analyse them with respect to the arterial wall structure. The analysis is done 
while following the development timeline of these manufacturing techniques in the vascular implant 
industry. This approach will provide an understanding of the degree of success, which has been achieved 
by textile-based implants in mimicking the mechanics of native arteries since their first clinical 
introduction. Some innovative design concepts, which have attempted to reduce the mechanical property 
mismatch between the implant and the host artery, are also discussed. These works are thought to 
encourage the design of longer lasting vascular implants in future.  
2. Artery: Structure and Mechanical Behaviour  
The primary step towards designing a vascular implant with improved mechanical response is to 
understand the arterial structure, its components and mechanical role of each component. An arterial 
wall is composed of three major layers namely, tunica intima, tunica media, and tunica adventitia [11]. 
The intima or the endothelial layer comprises of a single layer of endothelial cells. The tunica media is 
the thickest layer and composed of circumferentially arranged elastic fibres, smooth muscle cells, and 
collagen fibres. The outermost adventitia layer comprises of large diameter collagen fibres oriented 
longitudinally as wavy bundles. The mechanical behaviour of an artery is based mainly on the thickness 
of media layer and its main structural components (elastin and collagen), which differ significantly in 
their elastic modulus (elastin = 0.6–1 MPa, collagen = 1 GPa) [2,3]. The function of both these 
components was investigated by Roach and Burton by selectively dissolving them and comparing the 
J. Funct. Biomater. 2015, 6 503 
 
 
mechanical behaviour of the altered artery [1]. The study demonstrated that the initial slope in a typical 
stress-strain curve of an artery was contributed entirely by elastin fibres, while the final slope was due 
to collagen fibre stress response (Figure 2). The mid region (upturning region) involves successive 
transition or shifting of load from elastin to collagen and corresponds to the normal in vivo operating 
range (80–120 mmHg) of an artery. The non-linearity or incremental elastic modulus property is due to 
the wavy and random configuration of elastin and collagen fibres when unpressurised. With increase in 
pressure, elastin and collagen fibres start to straighten progressively. Elastin fibres become nearly 
straight at lower end of physiological pressure (80 mmHg). A further increase in pressure results in 
stretching of elastin and successive straightening as well as stretching of collagen fibres until top end of 
the physiological range (120 mmHg) is reached. An increase in pressure beyond this region (upturning 
region) results in fully stretched collagen and elastin fibres where stress response of collagen fibres 
dominates the arterial behaviour. This non-linear stress-strain behaviour is considered to be the key to 
elastic stability in arteries, which protects them from developing pathological conditions of aneurysms 
and ‘blowout’ at high pressures. The mechanical behaviour of arteries is also controlled by relative 
proportion of collagen and elastin fibres. High elastin content in ascending aorta (41% of dry weight) 
compared to descending aorta (30% of dry weight) is the reason behind a decreasing compliance trend 
observed while moving downstream in an aortic vessel [12,13]. 
 
Figure 2. Role of fibrous components (elastin and collagen) in shaping the pressure-diameter 
relation of an artery. 
The mechanical performance of an artery in the upturning region is expressed in terms of compliance 
value (percentage increase in diameter for a given increase in pressure) (Figure 2). A high compliance 
value indicates optimum level of structural performance for maintaining pulsatile blood flow. The 
property of an artery to support pulsatile flow is also known as the windkessel function, and is critically 
important in arteries in proximity of the heart such as the aorta [14]. During systole, the heart pumps 
nearly 60–100 mL of blood into the aorta while there is no supply during diastole. The windkessel 
function assists in temporarily storing a portion (approx. 50%) of systolic blood volume in aorta which 
can be later used during diastole to maintain consistent blood flow throughout the arterial network 
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(Figure 3). During this process, the cross-sectional area of aorta (ascending aorta) can increase by 11% [15]. 
The basis of windkessel function lies in the compliance property, as a non-compliant (stiff) aortic vessel 
cannot expand sufficiently to store blood.  
 
Figure 3. The role of compliance in the windkessel function of aorta. 
Anisotropy is another important characteristic of arterial wall attributed to circumferential orientation 
of collagen fibres and their unequal orthogonality in unstressed state. Arterial tissue is 40% stiffer in 
circumferential compared to axial direction and approximately 100% stiffer when inflated to 
physiological pressures [16]. Viscoelasticity or stress relaxation is a decisive component of arterial 
elasticity property. When an artery is subjected to cyclic inflation-deflation stresses, viscoelasticity 
causes hysteresis in pressure-volume curve. The area enclosed by hysteresis loop represents the energy 
lost in each cycle, which indicates that a major component of strain energy is recovered elastically each 
time arterial wall is distended [2]. The dissipation of strain energy due to viscoelasticity assists in 
attenuating forward pressure pulses, which propagate along arteries as waves of circumferential 
distention. Additionally, viscoelastic property has been suggested to improve the fatigue life of arteries 
by reducing dynamic stresses and strains in the wall [17].  
3. Textile Structures as Vascular Implants  
The incorporation of textiles as vascular implants started in 1952 with the pioneering work of 
Voorhees and colleagues who replaced diseased aortic vessels of dogs with woven Vinyon-N  
(a polyvinylchloride) tubes [18,19]. Within few years of Voorhees’s work, a number of studies reported 
clinical trials with different types of materials (Nylon, Teflon®, Dacron®, Orlon®), and constructions 
(woven, knitted, braided) in various diameters (6–20 mm) [20,21]. The role of manufacturing technique 
should be considered when deciding on parameters such as the handling and in vivo behaviour of the 
grafts. The definition of an ideal vascular implant requires it to be (1) biocompatible, (2) non-thrombogenic, 
(3) compliant, (4) fatigue resistant, (5) flexible yet robust, (6) readily available, and (7) easy to 
manufacture. Among these, attributes 3–7 are influenced by the manufacturing method used and 
structural design of the implant, while attributes 1–2 are contributed by material selection. There are a 
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number of techniques used to manufacture medical textiles and those that are used for vascular implants 
are mainly weaving, knitting, braiding and electrospinning. Each of these techniques presents specific 
characteristics and benefits which led to varying suitability for different types of vascular implants.  
3.1. Weaving  
A woven graft is manufactured by interlacing two sets of yarn (warp and weft) oriented at 90° to each 
other. These grafts are currently available in different types of weave designs namely, plain, twill, and 
satin (Figure 4). The main characteristics which were considered important while introducing these 
grafts in clinical practice were surface smoothness, handling ease, non-reactivity, water permeability, 
bursting strength, suture retention strength, and biological healing response [22–26]. On the other hand, 
biomechanical optimisation of graft design was largely overlooked in the last six decades since the 
conception of this great innovation. This is also indicated by the fact that the basic construction  
(a homogenous single layer woven fabric) of a woven graft has remained the same since its introduction 
in the 1950s. 
 
Figure 4. Structural design patterns of a woven Dacron® graft. 
A commercial woven graft can be considered similar to a windcheater jacket from structural and 
material perspective, and bears no relationship to the composite design principle of an artery. The 
dissimilarity is apparent when the fibre itself is analysed, whereby the elastic behaviour of polyester 
fibres corresponds to collagen fibres while no graft component performs the role of elastin fibre, i.e., 
low stress elastic response (Table 1). Furthermore, at the structural level, the straight yarn interlacement 
in woven grafts is unlike the helically arranged wavy configuration of collagen fibres, which induces 
non-linearity property in an artery. The orthogonal arrangement of both yarn components results in low 
axial elongation and poor radial compliance properties in these grafts [27]. The desired axial elasticity 
is often achieved through graft crimping, which also helps maintain tubular shape of graft during 
bending. However, optimum compliance is still an unachieved goal even with numerous proofs of its 
clinical importance [28–30].  
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Table 1. Elastic modulus of components of an artery [31] and a woven Dacron® graft.  
(* Stainless steel strut in a woven stent-graft).  
Structure Component Elastic Modulus (MPa) 
Artery 
Elastin 0.6–1 
Collagen 1000 
Smooth Muscle 0.1 
Woven graft 
Dacron® Polyester 800–900 
Stainless steel* 190 × 103–210 × 103 
The consequences of poor compliance can be fatal as it can change the transmission characteristics 
of pulse waves [4,32,33]. Moreover, a compliant host artery expands more than the stiff graft, which 
creates an abnormal stretch on the suture line. The continuous stretch subsequently produces structural 
fatigue of the arterial wall at the anastomosis [5]. A significant amount of research has been done on 
optimising construction and handling properties of woven grafts [34–39] but radial compliance/elasticity 
is still an unresolved issue [27,40] and has a direct influence on long term patency of these grafts (Table 2). 
Table 2. Comparison of compliance property of Dacron® grafts with natural blood vessels. 
Adapted from [33]. 
Structure Compliance (mmHg × 10−2) 
Artery 7.4 
Vein 2.7 
Dacron® Polyester (Woven) 1.9 
Dacron® Polyester (Knitted) 2.3 
There are very few studies that report initiatives to match graft mechanics to the host artery. These 
include studies published soon after the work of Voorhees, which attempted to tackle graft plasticity by 
using elastic filaments (Lycra® spandex) [41], and crimped synthetic filaments (Helanca® nylon and 
Dacron® polyester) [42,43]. Their concept was based on mimicking the role of wavy collagen and elastin 
fibres by using crimped and elastic yarns, respectively. Later, the combined use of both these 
components in plain weave constructions was successfully reported [44,45]. This approach improved 
the compliance nearly 17 times compared to a commercial woven graft (0.0324 ± 0.0083 kPa−1 vs. 
0.00186 ± 0.0005 kPa−1) and the new compliance matched that of a human common carotid artery 
(0.0238 ± 0.0132 kPa−1) [44]. However, from the design perspective, woven graft was still in its primitive 
single layer fabric stage.  
In 2011, an innovative woven graft design concept was reported by Chen et al. based on the coaxial 
graft concept of Sonoda et al. [46,47]. In this work, a bilayer woven graft prototype was developed in 
which the inner layer was constructed from low modulus yarns (poly-trimethylene terephthalate) while 
the outer layer made from high modulus yarns (polyester) was stitched in a crimped form to the inner 
layer (Figure 5). This type of structure can mimic the layered structure of blood vessels in a way that the 
strain at lower pressures is absorbed by the inner layer while a further increase in pressure will cause the 
outer layer to uncrimp and “join-in” with the inner layer to increase the overall elastic modulus of the 
graft. The authors reported a similar observation where elastic modulus of the new graft remained low, 
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up to 80 mmHg and increased rapidly afterwards [46]. However, a drawback of this design is reduced 
bending flexibility or kink resistance due to the crimped outer layer, which may limit its clinical applicability.  
 
Figure 5. An explanation of thebilayer woven graft design concept proposed by Chen et al. [46]. 
While in vitro studies can provide proof of concept confirmation for new designs, in vivo studies, 
whether on animals or human beings, provide more convincing evidence of their performance in actual 
clinical environment. One of the early long-term animal studies established the advantage of bi-component 
graft design (spandex and Dacron®) in improving graft mechanical properties [45]. The graft was 
sufficiently compliant (6.9%, 80/100 mmHg; 9.5%, 80/200 mmHg) even after one year of implantation 
and did not show any plastic dilatation at explantation after three years. Unfortunately, no published  
in vivo trial data is available for rest of the new designs discussed above [44,46,47].  
3.2. Knitting 
Knitted grafts have a looped filament construction in which a continuous interconnecting chain of 
yarn loops spirals around the graft circumference. Knitted structures are softer, more flexible, compliant, 
and have better handling characteristics than woven structures. The most common types of knits, which 
are used for graft design, are the weft knit and warp knit constructions (Figure 6). Warp knitted structures 
have less stretch than weft knits, and therefore are inherently more dimensionally stable. The knitted 
grafts were first introduced in clinical practice in 1955 with the intent to remove the seam problem in a 
woven graft [48]. Later, in 1958, the renowned heart surgeon Dr. Michael DeBakey firmly established 
the clinical usefulness of knitted Dacron® grafts [49,50]. The trend of using Dacron® as a standard graft 
material started thereafter owing to the better long-term biostability of Dacron® compared to other 
available materials (Nylon and Orlon®). Improved stretch widthwise (radial compliance) compared to 
woven grafts was a promising observation in knitted grafts. However, high porosity and long-term 
dilatation were also reported [26,41]. The reason being absence of structural heterogeneity in knitted 
grafts as in arteries which protects them from undergoing fatigue dilation. Since then, several studies 
have been published reporting the use of different coating techniques, constituent materials, and knitted 
patterns with a motive to improve handling, fatigue and biological performance of these grafts [51–59]. 
Based on the inherent structural flexibility of knitted structures, many investigations have reported their 
use as elastic tubular substrates [60–64]. This property also formed the reason behind the use of 
monofilament knitted mesh structures as vascular stents [65–69]. However, commercially available 
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knitted implants do not vary much in their structure, which is mainly a plain knit single layer 
homogenous structure bearing resemblance to an upholstery fabric rather than to an artery. In addition, 
Dacron® has been the only material for commercial knitted grafts since its use was first proposed by 
DeBakey [49]. Although Dacron® grafts are currently used in the clinics, there is a significant mismatch 
between their mechanical behaviour in comparison to natural arteries (Table 2) [40].  
 
Figure 6. Structural design patterns of a knitted Dacron® graft. 
Similar to woven grafts, knitted grafts also underwent design trials to improve their elastic behaviour. 
The first report on use of spandex filament knitted graft as a dog abdominal aorta (diameter 8–10 mm) 
was presented by Wagner et al. [41]. However, the solo use of spandex fibre as graft material was 
observed to cause long-term dilatation defect in the graft and is attributed to homogenous single layer 
structure of the graft. Some of the latest studies tried to use a composite polyester/spandex filament yarn 
to improve graft elasticity [62,64]. This type of material composition allows load sharing among both 
components and can prevent dilatation issues if structural design pattern is also modified. However, 
these studies only report basic improvements in mechanical properties of a plain weft knit structure and 
lack the ability to be considered as a significant design improvement to mimic arterial mechanics in a 
knitted graft.  
In a recent study, an innovative knitted stent-graft design was reported which closely mimics the 
natural artery mechanical behaviour [70]. The design is based on the concept of longitudinal structural 
segmentation or metamerism in which the knitted tube is divided into multiple low and high modulus 
segments arranged in alternating sequence (Figure 7). The low modulus (knitted polyurethane) sections 
tend to remain contracted (reduced diameter) when unpressurised while high modulus (knitted polyester) 
maintain the as-knit configuration. Therefore, at low internal pressure, the expansion of low modulus 
segments controls the stress response of the knitted tube until their circumference equals that of high 
modulus segments. At high pressures, the combined response of both the segments increases the stress 
response sharply, exhibiting an incremental elastic modulus property similar to natural arteries. The low 
modulus segments act as intermittent “buffer zones” which assist in radial expansion as well as provide 
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a kink-free configuration to the knitted tube. The compliance of this new design (volumetric:  
0.056 ± 0.006 mL/mmHg; radial: 9.8 × 10−4 mmHg−1) is nearly 7 and 15 times better compared to a 
conventional knitted stent (radial: 1.45 × 10−4 mmHg−1) and a commercial woven Dacron® graft 
(volumetric: 0.0038 ± 0.002 mL/mmHg), respectively, and falls well within the physiological range of 
aortic vessel [70,71]. However, the in vivo performance of this design is still unavailable to demonstrate its 
clinical performance. 
 
Figure 7. The segmented design concept as proposed by Singh and Wang to improve the 
compliance property of a knitted vascular implant [70,71].  
3.3. Braiding 
The application of braided textiles in traditional application areas (apparel, upholstery) is very limited 
compared to knitted and woven structures and is mainly found in technical textiles (industrial, sports, 
automotive). Braiding technique involves the use of three or more component yarns, which are 
intertwined at an angle to each other. In other words, braided structures are similar to traditional woven 
structures but with an angle bias. The angled mesh structure allows easy radial expansion of braided 
tubes. This property formed the basis of using braiding in the early years of textile graft innovation [72–75].  
The advent of endovascular technology in the 1990s led to the search for user-friendly stent designs [76]. 
The ability of tubular braided structures to compress easily and recoil back made them a promising 
candidate for self-expanding vascular stents [77]. Low bending rigidity of braided mesh tube was also 
an additional advantage for stent application. However, radial expansion in braided tubes occurred at the 
expense of axial shortening and elastic recovery was limited to open mesh braids only. Also, braided 
stents were not very successful in endograft application as it required suturing/bonding of a tubular graft 
to stent wires and, hence, limited the movement of constituent wires at their cross-over points which 
ultimately led to stent failure (wire breakage) under cyclic, in vivo conditions [78]. This limitation shifted 
braided stents towards stent applications which do not require graft covering, suitable for peripheral 
atherosclerotic arteries, which is also their current main application area (Table 3) [79].  
The commercially available braided stents are made from various metallic alloys (Table 3), which 
make them highly non-compliant and mechanically similar to a braided plumbing hose (Figure 8). Since 
low porosity is an important requirement in flow diverter stents, the number of wires is generally kept 
high (up to 96) to increase mesh density [80–83]. Similarly, compression of atherosclerotic region 
requires high radial compression strength, which is generally achieved by increasing mesh density. 
However, an inverse effect of high mesh density is increased stent stiffness (radial and longitudinal), 
which has a negative impact on the host artery hemodynamics [84,85]. The arterial length covered by 
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the stent becomes non-compliant and results in pressure attenuation across this region and localised 
increase in pulse-wave velocity. A stiff metallic stent also causes straightening of the host artery and 
may induce kinks [86]. The development timeline of braided vascular stents to date mainly includes 
trials with various polymeric filaments [65,87–96] and stent parameter optimisation studies [89,96–100], 
while improvement in conventional braided design (a single component homogenous construction) to 
match arterial mechanics was rarely investigated.  
Table 3. Categorisation of commercial braided stents according to their application area, 
material and design feature. 
Trade Name Manufacturer Application Material Design Feature 
PIPELINE® ev3 Inc. 
Flow diverter stent 
Cobalt-Chromium 
+ Platinum 
Single layer 
braided tube 
p64® Phenox GmbH Nitinol 
LEO® PLUS 
Balt Extrusion 
Nitinol 
SILK® Nitinol + Platinum 
LVIS Device® MicroVention Inc. Nitinol 
WALLSTENT™ Boston Scientific Co. 
Carotid stent 
Elgiloy® 
ROADSAVER® Terumo Nitinol 
SUPERA® Abbott Vascular Peripheral stent Nitinol 
Agili-D® Altura Medical Abdominal endograft Metal alloy 
 
Figure 8. Structural geometry of a braided metallic stent (α = braid helix angle).  
The research contribution towards improving braided stent mechanics is very limited but still worth 
mentioning. The concept of using a multilayer braid design was introduced to reduce porosity of the 
stent while maintaining the bending flexibility, which otherwise becomes too low in a high mesh density 
single layer stent to be able to conform well to the arterial wall. The use of multiple layer braided stent 
has been trialled in many clinical studies and is commercially available as CARDIATIS® multilayer 
stent [101–103]. Another new design concept was reported recently which is a single layer braided 
structure but with two different zones/sections along its length [104,105]. The central zone (70% of stent 
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length) is a tightly braided high mesh density section while the margins have low mesh density. This 
allows reduced blood flow to the diseased portion of the blood vessel while maintaining flexibility in 
rest of the “non-functional” stent length. The commercial version of this design is available as  
E-volution® stent (Jotec GmbH, Germany). Marchand et al. tried to improve the radial compliance of a 
braided heart valve stent by optimising shape-setting parameters of the stent material (nitinol alloy) [106]. 
The modified heat treatment process was reported to improve radial expandability of the stent when 
tested in an in vitro test experiment.  
3.4. Electrospinning  
Since their introduction, Dacron® grafts (woven and knitted) have dominated the vascular graft 
market in large diameter (15–30 mm) blood vessel replacement. Dacron® grafts have also been used as 
replacements for small diameter (<6 mm) arteries (coronary, below-the-knee, tibial, and peroneal). 
However, there were a number of limitations identified such as owing to mismatched compliance, graft 
thrombosis, and anastomotic intimal hyperplasia (Table 4) [6,23,107–110]. One of the most commonly 
used strategies to address some of these limitations is by coating the synthetic grafts with protein such 
as collagen. As shown in Table 5, the general trend observed is that grafts coated with collagen, fibronectin 
or heparin demonstrated better cell attachment in vitro and improved patency in vivo [111–114]. 
Table 4. Compliance and cumulative patency of different arterial grafts implanted in a small 
diameter (femoropopliteal artery) position. Adapted from [115]; PTFE, Polytetrafluoroethylene.  
Graft Type 
Compliance  
(% mmHg × 10−2) 
Structure 
Patency % 
(30/180 days) 
Patency % 
(1/2 years) 
Human femoral artery 5.9 – – – 
Saphenous vein 4.4 Natural tissue 94/93 88/84 
Umbilical vein 3.7 Natural tissue 97/93 83/80 
PTFE 1.6 Extruded (non-textile) 85/81 60/42 
Dacron® 1.9 Woven 88/72 65/42 
The graft structure (porosity, fibre diameters, pore connectivity, surface area, and compliance) is 
important as it influences cell growth behaviour. This led to the development of a new textile fibre 
spinning technique known as electrospinning, which is capable of producing fibres to the scale of native 
collagen and elastin fibres. In an electrospinning process, a strong electric field is generated between a 
polymer solution (delivered through a syringe needle) and a metallic collector. When the voltage reaches 
a critical value, the charge overcomes the surface tension of the polymer solution drop at the needle tip 
and polymer jet is generated. While travelling towards the metallic collector the drawing force exerted 
by electric field and simultaneous evaporation of the solvent results in reduction in the diameter of the 
jet. The collected dry fibres form a nonwoven mesh of nanometre to micrometre diameter fibres (Figure 9). 
The process can be adjusted to control fibre diameter to some extent by varying the charge density and 
polymer solution concentration. The feature of producing very fine fibres increases the surface area 
significantly in electrospun meshes, which is a beneficial property for improving cell growth [116].  
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(a) (b) 
Figure 9. The wall thickness (a) and surface (b) view of an electrospun mesh.  
The structural construction of an electrospun fibre scaffold can closely mimic the natural extracellular 
matrix structure [117]. Electrospinning also enables the use of a wide range of natural and synthetic 
polymers [118], thus, increasing the possibility of matching both the biological and mechanical 
properties similar to an artery (Table 5) [119]. The electrospinning of natural proteins like collagen and 
elastin have demonstrated the usefulness of this technique to bring synthetic vascular grafts near to their 
biological counterparts [120,121]. From a structural design perspective also, electrospinning provides a 
range of possibilities in mimicking the multilayered construction of arterial wall [122–125]. The use of 
different polymeric components in individual layers provides more flexibility in controlling the graft 
mechanical response from each structural layer. 
Table 5. Biological responses in various types of synthetic vascular grafts created from 
different manufacturing techniques.  
Technique Material 
Scaffold 
Dimensions 
Biological Response Mechanical Testing Ref. 
Knitted PET 4 mm diameter 
ECs: Better cell attachment was 
observed on precoated grafts in the 
following order: collagen (3.5 × 105 
cells/cm2) > fibrin (2.8 × 105 cells/cm2) 
> fibronectin (2.4 × 105 cells/cm2) > 
laminin = untreated  
(1.3 × 105 cells/cm2) 
– [126] 
Knitted PET 
4 mm diameter 
cut into fusiform 
patches of  
5 cm length ×  
8 mm width 
In vivo: Implanted in sheep for 4 weeks 
and intimal hyperplasia assessed. 
Fluoropolymer coated PET sealed with 
gelatin produced the least amount of 
hyperplasia followed by PTFE, 
carbonlined PTFE and gelatin sealed 
PET 
– [127] 
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Table 5. Cont. 
Technique Material 
Scaffold 
Dimensions 
Biological Response Mechanical Testing Ref. 
Knitted PET – 
In vivo: Randomised clinical trial of 209 
patients (femoropopliteal bypass). Patency 
at 3 years of collagen-coated heparin 
bonded PET (54%) was better than PTFE 
(44%). No difference in patency at 5 years 
between PET and PTFE 
– [128] 
Woven and 
Electrospinning 
PET and 
PU  
Flat 
In vitro (HUVECs): All 3 materials 
showed better cell attachment when coated 
with Collagen Type I/III as compared to 
their uncoated counterparts. Cell coverage 
on coated PTFE (34.6%) > PET (19.6%) 
> PU (17.5%); 
When exposed to shear stress of 1 Pa for 1 h, 
cell retention was highest on coated PTFE. 
No difference was observed across the 3 
materials when shear stress increased to 2 Pa 
– [129] 
Electrospinning 
PCL and 
PU 
NS 
In vitro (HUVECs): Good cell attachment  
(~ 61%). Cells produced proteins such as 
PECAM and vWF, indicating normal 
phenotype and function 
– [130] 
Electrospinning Silk fibroin 1.5 mm diameter 
In vivo: Implanted in rats for 7 days to 6 
months. No graft degradation or foreign 
body reaction observed. 95% of grafts 
remained unblocked. After 1 month 
implantation, ECs were observed on the 
luminal surface of the grafts. Cell coverage 
continue to increase at 6 months 
– [131] 
Electrospinning Silk 5 mm diameter 
In vitro: ECs and SMCs attached and 
proliferated on the scaffold. ECs were 
observed on the surface of the scaffold 
while SMCs migrated into the scaffold 
Tensile strength:  
2.42 MPa; 
Elastic modulus:  
2.45 MPa; 
Mean burst pressure: 
811 mmHg 
[132] 
Electrospinning PCL 2 mm diameter 
In vivo: Implanted in rats for 24 weeks. No 
narrowing of the grafts (stenosis) in the 
PCL group. ECs coverage confluent at 12 
weeks in the PCL group vs. ePTFE group 
(incomplete at 24 weeks). 
– [133] 
Electrospinning PCL NS 
In vitro: A confluent layer of oriented 
SMCs in the direction of aligned fibres 
after 7 days culture 
– [134] 
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Table 5. Cont. 
Technique Material 
Scaffold 
Dimensions 
Biological Response Mechanical Testing Ref. 
Electrospinning 
Collagen 
Type 1, 
elastin and 
PLGA 
Tubular  
(4.75 mm 
diameter,  
12 cm long) 
In vitro: Mean of 72% for ECs and 
82% for SMCs viability over 7-day 
culture period; 
In vivo (mice): No systemic or 
neurological toxicity, normal blood 
count, transient local inflammation at 
implantation site 
Burst pressure: 1425 mm Hg; 
Compliance: 12%–14% for 
scaffold vs. 9% for native vessel; 
Maximal axial and 
circumferential strain: 40% strain 
[119] 
Electrospinning 
Collagen 
and PCL 
Tubular  
(4.75 mm 
diameter,  
12 cm long) 
ECs: Cytoskeletal organisation and 
focal adhesion via actin and vinculin 
staining respectively were better 
developed when cultured on smaller 
sized fibres; 
SMCs: Infiltration of cells into 
scaffolds with fibres > 1 µm in 
diameter during  
a 4-week culture 
Tensile strength: Increasing 
fibre diameter (0.27 µm  
to 4.45 µm) decreased tensile 
strength from 3.15 MPa  
to 0.75 MPa; 
Elongation at break: Increased 
with increasing fibre diameter 
(90% for 0.27 µm fibres to 
734% for 4.45 µm fibres); 
Maximum load: Decreased 
from 25.75 N (0.27 µm fibres) to 
8.63 N (4.45 µm fibres) 
[135] 
Knitting 
Elastin 
solubilised 
proteins 
and PET 
Flat 
HUVECs: No cytotoxicity, 43% cell 
attachment for elastin solubilised 
protein-PET vs. 94% for PET 
– [136] 
Electrospinning 
Elastin and 
PDO 
6 mm 
diameter 
In vitro: Fibroblasts cultured for 7 
days on PDO:Elastin graft showed 
migration into the fibrous materials 
vs. no migration in PDO graft 
PDO:Elastin ratio of 50:50 
produced compliance that 
mimics native femoral artery 
[137] 
Electrospinning 
PCL,  
PDO and 
Silk 
NS 
In vitro: Risk of clotting using 
human monocytes – PCL < Silk < 
PDO. The risk in PCL is comparable 
to ePTFE (currently used grafts  
in clinics) 
– [138] 
Electrospinning 
Chitosan 
and PVA 
NS 
In vitro: Good fibroblast growth was 
observed with continual proliferation 
up to 21 days 
– [139] 
EC = endothelial cell; ePTFE = expanded polytetrafluoroethylene; HUVEC = human umbilical vein endothelial cell;  
NS = not specified; PCL = polycaprolactone; PDO = polydioxanone; PET = polyethylene terephthalate;  
PLGA = poly(lactic-co-glycolic acid); PTFE = polytetrafluoroethylene; PU = polyurethane; PVA = polyvinyl alcohol; 
SMC = smooth muscle cell. 
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4. Discussion  
The woven graft development timeline suggests that this technology has shown biomechanical 
benefits of using new structural components but there are very limited attempts which focus on 
improvising conventional weave designs to suit the arterial site. Knitted structures appear to be a suitable 
candidate for vascular implant application owing to their inherent structural and design flexibility. Also, 
anisotropic elasticity property (axial > circumferential) in knitted structures is similar to that of the native 
artery, which is an advantage over woven structures. Currently, some of the latest developments in 
woven and knitted grafts use biological coatings to improved tissue growth and design modifications to 
match the implant site anatomy, while the lack of innovation from material and biomechanical aspect is 
evident in new commercial products (Table 6). The future products may require a combined input from 
advanced textile designing and biomechanics together in order to realise the full clinical potential of 
textile grafts. The helical arrangement of constituent filaments/wires give braided structures a design 
advantage over woven and knitted structures to mimic the helical geometry of collagen and elastin fibres 
in an artery. However, the focus on this aspect of braided stent improvement is mostly unrealised. Since, 
braided stents are deployed in their fully expanded state (helix angle approaching 90°), the low stress 
radial expansion property owing to helical geometry is completely lost (Figure 8). The use of elastic 
filaments and design of bio-component structures can be a future prospect for developing compliant 
braided stent devices. Expanded polytetrafluoroethylene (ePTFE) is an inert fluorocarbon polymer 
(stiffness: 0.5 GPa, tensile strength: 14–18 MPa), which is developed by heating, stretching, and 
extruding process resulting in a porous polymeric structure. Non-textile grafts made from ePTFE are 
currently used in the clinics as medium diameter grafts (7–9 mm) for peripheral vascular diseases. 
However, ePTFE grafts are not viable as conduits for small diameter (<6 mm) vessel replacement due 
to a high rate of occlusion. Although ePTFE is a chemically inert material, the structural stiffness and 
low radial compliance of these grafts contributes to their poor long-term patency (Table 4). There have 
been numerous investigations into endothelial cell seeding and surface functionalization of ePFTE grafts 
to improve their clinical performance as small diameter grafts. Current efforts have yet to produce a 
small diameter synthetic graft that is comparable to an autologous graft. Electrospinning technique has 
proven to be a promising option for small diameter grafts in many in vitro and animal studies. In 
comparison to established textile manufacturing methods (weaving, knitting, braiding), this technology 
is equipped with much higher levels of design flexibility in terms of material variety (natural, synthetic), 
structural heterogeneity (multi-layer, multi-component), and therapeutic ability (drug delivery). However, 
development of an off-the-shelf electrospun graft product capable of achieving rapid cell coverage with 
minimised risk of thrombosis, intimal hyperplasia, and mechanical failure has yet to be achieved.  
Radial compliance is unarguably the most vital mechanical feature requirement from a synthetic 
vascular implant. In conjunction with compliance, non-linearity and anisotropy are two critical 
mechanical characteristics, which a vascular graft must also possess in order to successfully mimic 
natural artery mechanics. Non-linearity prevents the late development of pathological conditions related 
to graft failure at high pressures [2,3]. Anisotropic mechanical property prevents excessive stimulation 
of anastomotic region, while being compliant in radial direction to prevent any flow disturbances [125]. 
In an artery, both these properties are achieved owing to the multilayered heterogeneous structure of 
arterial wall, which a single-layer single-component isotropic textile structure is unable to mimic. 
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Table 6. A list of selected commercially available Dacron® grafts and their design features. 
Structure Material Trade Name 
Special Design 
Feature 
Intended 
Improvement 
Manufa-
cturer 
Application 
Area 
Woven 
Dacron® 
& PTFE 
FUSION BIOLINE® 
Two layer, 
Heparin coated 
Improves patency 
and healing response 
Macquet 
Peripheral 
Dacron® 
HEMASHIELD® PLATINUM 
Multiple branched, 
Double velour, 
Collagen coated 
Enhances healing 
response 
Aortic 
VASCUTEK® GELWEAVE™ 
Pre-curved 
Pre-curved design 
Matches aortic arch 
anatomy 
Terumo 
VASCUTEK® SIENA™ 
Extended trunk 
and collar design 
Suits hybrid surgery 
procedures 
VASCUTEK® GELWEAVE™ 
Plexus 
Multiple branched, 
Gelatin 
impregnated 
Suits complete aortic 
arch surgery 
VASCUTEK® GELWEAVE™ 
Valsalva 
Extended skirt 
design 
Matches aortic root 
anatomy 
VASCUTEK® GELWEAVE™ 
Ante-Flo 
Extra branch 
Reduces surgery 
time, Lowers risk of 
neurological deficits 
E-VITA™ OPEN PLUS 
Extended stented 
trunk 
Suits hybrid surgery 
procedures 
Jotec 
Knitted 
INTEGRAD® SILVER Silver impregnated 
Reduces graft 
infection 
Macquet 
Aortic, 
Peripheral 
HEMAGARD® Ultrathin 
Collagen coated, 
Wall thickness = 
0.35 mm 
Improves healing 
response, Reduces 
dilatation, Increases 
suture strength 
Aortic 
HEMASHIELD® GOLD 
Collagen coated, 
Double velour 
surface 
Improves healing 
response, Reduces 
dilatation, Increases 
suture strength 
VASCUTEK® GELSEAL™ 
Gelatin 
impregnated 
Improves healing 
Terumo 
Aortic, 
Peripheral VASCUTEK® GELSOFT™ 
ERS 
Gelatin 
impregnated, 
Radially supported 
Improves healing and 
handling 
FLOWNIT BIOSEAL® 
Texturised yarn, 
Collagen 
impregnated 
Low dilatation, 
Enhances tissue 
incorporation 
Jotec Aortic 
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5. Conclusions 
This paper reviewed the design aspect of medical textiles (woven, knitted, braided, electrospun) 
intended for vascular implant applications. The three dimensional structure of an arterial wall and its 
unique mechanical properties (anisotropy, non-linearity, compliance, viscoelasticity) have been widely 
researched and reported. However, these features remain widely unconsidered while designing synthetic 
vascular implants. Therefore, the vascular implants used currently in clinics serve the function of a rigid 
non-distensible conduit but lack the ability to revive lost biomechanical function of the diseased artery. 
Currently available textile vascular implants are not significantly different from those introduced six 
decades ago. Their structural geometry is analogous to traditional textile structures rather than to an 
arterial vessel. This difference is highlighted when late clinical complications arise from behavioural 
mismatch at the artery-implant anastomosis. These observations ultimately raise the importance of 
understanding the structure and biomechanics of an artery before adapting a textile structure from its 
conventional application area to a biological environment consisting of complex structure and functions 
such as the blood vessel. A synthetic vascular implant with structural characteristics that closely resemble 
a native artery will present with less complications, which, in turn, translates to a longer-lasting implant.  
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